Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Esophagus (All Stages^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate ascending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Recent Trend
Recent 5-Year Trend in Incidence Rates
(95% Confidence Interval)
 sort by trend descending
US (SEER+NPCR) 1 4.5 (4.5, 4.5) N/A 17,922 stable stable trend -0.1 (-0.4, 0.7)
Maine 6 6.8 (6.3, 7.3) 1 (1, 3) 140 stable stable trend 0.0 (-0.9, 1.0)
New Hampshire 6 6.3 (5.8, 6.8) 2 (1, 7) 123 stable stable trend -1.1 (-2.0, 0.0)
West Virginia 6 6.0 (5.6, 6.5) 3 (1, 9) 159 stable stable trend 0.5 (-0.3, 1.4)
Iowa 7 5.6 (5.3, 6.0) 4 (2, 15) 234 stable stable trend 0.5 (-0.8, 1.1)
Ohio 6 5.6 (5.5, 5.8) 5 (3, 10) 873 rising rising trend 2.6 (1.3, 4.8)
Vermont 6 5.5 (4.8, 6.3) 6 (1, 32) 51 stable stable trend 0.3 (-1.1, 1.9)
Alaska 6 5.5 (4.7, 6.3) 7 (1, 33) 42 stable stable trend -0.3 (-2.0, 1.6)
Kentucky 7 5.5 (5.2, 5.8) 8 (3, 16) 313 rising rising trend 4.6 (1.1, 6.8)
Wisconsin 6 5.3 (5.1, 5.5) 9 (4, 18) 406 stable stable trend -0.7 (-1.5, 0.1)
Pennsylvania 6 5.3 (5.1, 5.5) 10 (6, 16) 948 stable stable trend 2.0 (-0.3, 3.6)
Michigan 6 5.3 (5.1, 5.5) 11 (5, 18) 705 stable stable trend -0.5 (-0.9, 0.0)
Massachusetts 7 5.3 (5.1, 5.5) 12 (5, 18) 474 stable stable trend -0.1 (-2.3, 3.4)
South Dakota 6 5.2 (4.6, 5.8) 13 (2, 36) 59 stable stable trend 9.7 (0.0, 17.1)
Rhode Island 6 5.1 (4.6, 5.7) 14 (3, 35) 73 rising rising trend 6.5 (0.7, 10.9)
Missouri 6 5.1 (4.9, 5.3) 15 (7, 23) 409 stable stable trend -0.2 (-0.6, 0.2)
Minnesota 6 5.1 (4.9, 5.3) 16 (7, 23) 357 stable stable trend 3.2 (-0.5, 6.2)
North Dakota 6 5.0 (4.3, 5.7) 17 (3, 42) 44 stable stable trend 0.2 (-1.8, 2.3)
Nebraska 6 4.9 (4.5, 5.3) 18 (7, 35) 117 stable stable trend 0.2 (-1.1, 1.6)
Oregon 6 4.8 (4.6, 5.1) 19 (12, 33) 267 stable stable trend -0.8 (-1.6, 0.0)
Idaho 7 4.8 (4.4, 5.2) 20 (7, 39) 101 stable stable trend 0.0 (-1.0, 1.1)
Kansas 6 4.8 (4.4, 5.1) 21 (11, 36) 170 rising rising trend 1.3 (0.5, 2.2)
Oklahoma 6 4.8 (4.5, 5.1) 22 (12, 35) 229 rising rising trend 4.3 (0.2, 7.3)
Washington 5 4.7 (4.5, 4.9) 23 (15, 33) 432 stable stable trend -0.4 (-1.0, 0.3)
Tennessee 6 4.7 (4.5, 4.9) 24 (15, 33) 414 stable stable trend 0.5 (0.0, 1.1)
Illinois 7 4.7 (4.6, 4.9) 25 (16, 31) 752 falling falling trend -1.0 (-1.5, -0.6)
Mississippi 6 4.6 (4.3, 4.9) 26 (15, 40) 173 stable stable trend -0.6 (-1.9, 0.8)
Connecticut 7 4.5 (4.3, 4.8) 27 (16, 40) 221 falling falling trend -1.6 (-5.2, -0.8)
Montana 6 4.5 (4.0, 5.1) 28 (10, 45) 68 stable stable trend -1.0 (-7.7, 0.5)
Delaware 6 4.5 (4.0, 5.1) 29 (10, 46) 60 falling falling trend -1.9 (-3.3, -0.3)
Florida 6 4.5 (4.4, 4.6) 30 (23, 35) 1,437 falling falling trend -0.6 (-0.9, -0.2)
Louisiana 7 4.5 (4.2, 4.7) 31 (18, 40) 258 stable stable trend 1.5 (-1.7, 3.9)
Arkansas 6 4.5 (4.2, 4.8) 32 (18, 41) 176 stable stable trend 0.6 (-5.9, 3.5)
Alabama 6 4.4 (4.2, 4.7) 33 (20, 40) 287 falling falling trend -0.6 (-1.1, -0.1)
South Carolina 6 4.4 (4.2, 4.6) 34 (21, 41) 303 falling falling trend -1.8 (-2.5, -1.1)
Georgia 7 4.3 (4.2, 4.5) 35 (25, 41) 524 falling falling trend -1.1 (-1.6, -0.6)
New York 7 4.3 (4.2, 4.4) 36 (29, 41) 1,080 falling falling trend -1.5 (-4.1, -1.1)
New Jersey 7 4.2 (4.1, 4.4) 37 (29, 43) 486 falling falling trend -1.2 (-1.5, -0.8)
North Carolina 6 4.2 (4.0, 4.4) 38 (29, 43) 555 falling falling trend -1.0 (-1.5, -0.5)
Virginia 6 4.1 (3.9, 4.2) 39 (33, 45) 426 falling falling trend -1.3 (-1.9, -0.8)
Maryland 6 4.0 (3.8, 4.3) 40 (33, 46) 302 falling falling trend -1.7 (-2.2, -1.0)
Colorado 6 4.0 (3.8, 4.2) 41 (34, 46) 261 stable stable trend -0.6 (-1.4, 0.2)
Arizona 6 4.0 (3.8, 4.2) 42 (36, 46) 373 stable stable trend -0.6 (-1.4, 0.3)
Wyoming 6 4.0 (3.3, 4.7) 43 (16, 49) 29 falling falling trend -2.7 (-5.1, -0.1)
Texas 7 3.9 (3.8, 4.0) 44 (40, 47) 1,159 stable stable trend 0.0 (-0.7, 1.7)
District of Columbia 6 3.8 (3.2, 4.6) 45 (18, 49) 26 falling falling trend -4.8 (-6.9, -3.0)
Hawaii 7 3.7 (3.3, 4.1) 46 (36, 49) 71 stable stable trend -0.2 (-1.0, 0.7)
New Mexico 7 3.6 (3.3, 3.9) 47 (39, 49) 99 stable stable trend 0.0 (-0.7, 0.8)
California 7 3.5 (3.4, 3.5) 48 (45, 49) 1,565 falling falling trend -1.1 (-1.5, -0.7)
Utah 7 3.3 (3.0, 3.6) 49 (44, 49) 94 stable stable trend -0.4 (-6.0, 0.8)
Puerto Rico 6 2.8 (2.5, 3.0) N/A 124 stable stable trend -2.6 (-8.5, 3.6)
Indiana 6
data not available
N/A
data not available
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 04/20/2024 1:05 am.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
‡ Incidence data come from different sources. Due to different years of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each area for additional information.

Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2022 submission).
7 Source: SEER November 2022 submission.
8 Source: Incidence data provided by the SEER Program. AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modifed by NCI. The US Population Data File is used with SEER November 2022 data.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top